Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cogent Biosciences Inc (COGT)

Cogent Biosciences Inc (COGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 632,002
  • Shares Outstanding, K 95,613
  • Annual Sales, $ 0 K
  • Annual Income, $ -192,410 K
  • 60-Month Beta 1.50
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.81
Trade COGT with:

Options Overview Details

View History
  • Implied Volatility 114.79% ( -0.01%)
  • Historical Volatility 62.96%
  • IV Percentile 78%
  • IV Rank 40.78%
  • IV High 188.08% on 09/29/23
  • IV Low 64.31% on 06/26/23
  • Put/Call Vol Ratio 16.96
  • Today's Volume 1,293
  • Volume Avg (30-Day) 260
  • Put/Call OI Ratio 0.72
  • Today's Open Interest 7,173
  • Open Int (30-Day) 5,388

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.50
  • Number of Estimates 6
  • High Estimate -0.37
  • Low Estimate -0.55
  • Prior Year -0.54
  • Growth Rate Est. (year over year) +7.41%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.73 +17.10%
on 03/25/24
7.18 -6.55%
on 04/04/24
-0.02 (-0.30%)
since 03/19/24
3-Month
4.28 +56.78%
on 01/29/24
10.26 -34.60%
on 02/22/24
+2.12 (+46.19%)
since 01/19/24
52-Week
3.67 +82.83%
on 12/11/23
13.50 -50.30%
on 06/14/23
-4.55 (-40.41%)
since 04/19/23

Most Recent Stories

More News
Markets Today: Stocks Slightly Higher on Strength in Tesla and Netflix

Morning Markets June E-Mini S&P 500 futures (ESM2 3) this morning are up +0.09%, and June Nasdaq 100 E-Mini futures (NQM2 3) are up +0.11%. U.S. stock index futures this morning are slightly higher. Tesla...

ESM24 : 5,003.75s (-0.90%)
NQM24 : 17,180.75s (-2.09%)
TSLA : 147.05 (-1.92%)
NFLX : 555.04 (-9.09%)
PLAY : 53.70 (+0.13%)
AMZN : 174.63 (-2.56%)
YEXT : 5.46 (-0.55%)
SMCI : 713.65 (-23.14%)
NVCR : 12.09 (+0.33%)
CASY : 310.41 (+0.33%)
BASE : 22.90 (-2.64%)
UNFI : 9.27 (-0.86%)
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2022 Financial Results

On-track to present additional data from Phase 2 APEX trial by the end of 2022 Initial data from Phase 2 SUMMIT trial & lead-in data from Phase 3...

COGT : 6.71 (+1.51%)
Cogent Biosciences, Inc. (COGT) Is a Great Choice for "Trend" Investors, Here's Why

Cogent Biosciences, Inc. (COGT) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made...

COGT : 6.71 (+1.51%)
Wall Street Analysts See a 66% Upside in Cogent Biosciences, Inc. (COGT): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of 66.1% in Cogent Biosciences, Inc. (COGT). While the effectiveness of this highly sought-after metric is questionable,...

COGT : 6.71 (+1.51%)
Here's What Could Help Cogent Biosciences, Inc. (COGT) Maintain Its Recent Price Strength

Cogent Biosciences, Inc. (COGT) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made...

COGT : 6.71 (+1.51%)
Cogent Biosciences Announces Closing of Upsized Public Offering of Common Stock and Pre-funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares

CAMBRIDGE, Mass. and BOULDER, Colo., June 16, 2022 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on...

COGT : 6.71 (+1.51%)
Biotech Stock Roundup: BLUE Up on Regulatory Updates, RIGL's Pipeline News & More

Regulatory and other updates from bluebird (BLUE) and Rigel (RIGL) are a few key highlights from the biotech sector during the past week.

RIGL : 1.0800 (+2.86%)
BLUE : 1.0200 (+7.03%)
COGT : 6.71 (+1.51%)
VALN : 7.58 (-6.72%)
Cogent Biosciences Announces Pricing of Upsized Public Offering of Shares of Common Stock and Pre-funded Warrants

CAMBRIDGE, Mass. and BOULDER, Colo., June 13, 2022 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on...

COGT : 6.71 (+1.51%)
Cogent (COGT) Surges on Robust Data from Mastocytosis Study

Cogent's (COGT) bezuclastinib achieves robust effectiveness in patients with advanced systemic mastocytosis with a favorable safety and tolerability profile. Stock surges more than 58% on Jun 10.

ALKS : 23.85 (+0.38%)
AGLE : 12.01 (+8.79%)
COGT : 6.71 (+1.51%)
SESN : 12.5760 (+7.29%)
Company News for Jun 13, 2022

Companies In The News Are: DOCU, COGT, BA, SFIX.

BA : 169.82 (-0.24%)
COGT : 6.71 (+1.51%)
SFIX : 2.14 (-2.28%)
DOCU : 55.70 (-2.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Cogent Biosciences Inc. is a biotechnology company. It is focused on developing precision therapies for genetically defined diseases. The company's program consist PLX9486. Cogent Biosciences Inc., formerly known as Unum Therapeutics Inc., is based in CAMBRIDGE, Mass.

See More

Key Turning Points

3rd Resistance Point 7.41
2nd Resistance Point 7.17
1st Resistance Point 6.94
Last Price 6.71
1st Support Level 6.46
2nd Support Level 6.22
3rd Support Level 5.99

See More

52-Week High 13.50
Fibonacci 61.8% 9.74
Fibonacci 50% 8.59
Fibonacci 38.2% 7.43
Last Price 6.71
52-Week Low 3.67

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar